ZARPROLENG Trademark

Trademark Overview

On Tuesday, March 18, 2014, a trademark application was filed for ZARPROLENG with the United States Patent and Trademark Office. The USPTO has given the ZARPROLENG trademark a serial number of 79145816. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, March 19, 2024. This trademark is owned by Novartis AG. The ZARPROLENG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of symptoms in connection with oncology
zarproleng

General Information

Serial Number79145816
Word MarkZARPROLENG
Filing DateTuesday, March 18, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, March 19, 2024
Registration Number4590933
Registration DateTuesday, August 26, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 10, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of symptoms in connection with oncology
Translation of Words in MarkThe wording "ZARPROLENG" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSandoz AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Thursday, April 24, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, May 1, 2014ASSIGNED TO EXAMINER
Friday, April 25, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, April 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 3, 2014APPLICATION FILING RECEIPT MAILED
Wednesday, May 21, 2014NOTICE OF PUBLICATION
Tuesday, June 10, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 26, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, September 25, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, September 25, 2014FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
Friday, March 12, 2021CANCELLED SECTION 71
Thursday, May 1, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 12, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 1, 2022INVALIDATION PROCESSED
Friday, January 19, 2024CHANGE OF OWNER RECEIVED FROM IB
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, October 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, October 8, 2024DEATH OF INTERNATIONAL REGISTRATION
Friday, April 1, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, May 23, 2022TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

zarproleng connection oncology symptoms treatment preparations pharmaceutical